Navigation Links
Dyadic International Raises $3 Million in Private Placement of Convertible Notes
Date:10/5/2011

JUPITER, Fla., Oct. 5, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the "Notes") to five investors.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO)

The Notes will pay interest quarterly at a rate of 8% per annum and are convertible at the holder's option into shares of Dyadic common stock.  Unless converted, the Notes will mature on January 1, 2013.

Dyadic expects to use proceeds from this offering for working capital including continued investments in research and development, new product introductions and general corporate purposes.

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries. Please visit Dyadic's website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dyadic International Reports 2011 Second Quarter Financial Results
2. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
3. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
4. Dyadic to Present at the World Congress on Industrial Biotechnology & Bioprocessing
5. Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
6. New U.S. Patent Issued to Dyadic International
7. Dyadic International to Present at Advanced Biofuels Leadership Conference
8. Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
9. Dyadic International Reports 2010 Fiscal Year Financial Results
10. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
11. Dyadic International Reports 2010 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported its ... ended September 30, 2016. ... , SQI is a ... develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. ... $1.4 million more than tripling prior years revenue. ...
(Date:12/6/2016)... NY (PRWEB) , ... December 06, 2016 , ... ... integrator of custom industrial automation and IT solutions, today announced the company has ... has reliably delivered professionally executed automation and control systems integration services to leading ...
(Date:12/6/2016)... , Dec. 6, 2016  Creative Medical Technology ... , MD, PhD, FANA, FAAN to the Company,s Scientific ... and clinical trials to assist the Company,s clinical development ... AmnioStem product is a universal donor stem cell derived ... in animal models of stroke 1 .  ...
(Date:12/6/2016)... , ... December 06, 2016 ... ... “Company”), a company focused on discovery and development of precision treatments for ... is developing for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of ...
Breaking Biology Technology:
(Date:11/29/2016)... VILNIUS, Lithuania , Nov. 29, 2016 ... high-precision biometric identification and object recognition technologies, ... kit (SDK) for fingerprint recognition solutions that ... extract a fingerprint template using less than ... used in compact devices that have limited ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by ... Component (Hardware and Software), Function (Contact and Non-contact), Application, and Region - ... grow from USD 10.74 Billion in 2015 to reach USD 32.73 Billion ... Continue Reading ... ...
(Date:11/17/2016)... LONDON , Nov. 17, 2016 Global Market ... and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market ... Geographical analysis for Private Biobanks shows the highest Compounded Annual ... Asia-Pacific region during the analysis period 2014-2020. ... a CAGR of 9.95% followed by Europe ...
Breaking Biology News(10 mins):